Safety and tolerability of enteric-coated mycophenolate sodium in combination with steroids and two regimen of Neoral®, in de novo kidney transplant recipients:: 6 months interim results.: A randomized, multicentre, open, prospective controlled study.

被引:0
|
作者
Rostaing, L
Mourad, G
Legendre, C
机构
[1] Hop Rangueil, Toulouse, France
[2] Hop Lapeyronie, Montpellier, France
[3] Hop St Louis, Paris, France
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
222
引用
收藏
页码:219 / 219
页数:1
相关论文
共 50 条
  • [11] Efficacy and safety of enteric-coated mycophenolate sodium, cyclosporine and steroids in De novo pediatric renal transplant patients:: 6-month results
    Niaudet, Patrick
    Loirat, Chantal
    Foulard, Michel
    Tsimaratos, Michel
    Lemay, Djamila
    TRANSPLANT INTERNATIONAL, 2007, 20 : 313 - 313
  • [12] Assessment of two Neoral® administration strategies on renal function and efficacy in de novo renal transplant patients receiving entericcoated mycophenolate sodium, steroids and anti-IL2R antibodies:: 6 months interim analysis of a randomized, multicentre, open, prospective controlled study.
    Mourad, G
    Rostaing, L
    Legendre, C
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 219 - 219
  • [13] A randomized trial of intensified vs. standard dosing for enteric-coated mycophenolate sodium in de novo kidney transplant recipients: results at 1 year
    Arns, Wolfgang
    Sommerer, Claudia
    Glander, Petra
    Ariatabar, Toofan
    Porstner, Martina
    May, Christoph
    Paulus, Eva-Maria
    Shipkova, Maria
    Fischer, Wolfgang
    Liefeldt, Lutz
    Hackenberg, Ruth
    Schemmer, Peter
    Domhan, Sophie
    Zeier, Martin
    Budde, Klemens
    CLINICAL NEPHROLOGY, 2013, 79 (06) : 421 - 431
  • [14] Pilot Study To Evaluate the Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Combination with Sirolimus in De Novo Renal Transplant Recipients
    Peddi, V. R.
    Wilson, J.
    Mena, N.
    Lu, L.
    Miguel, M.
    Ueda, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 412 - 412
  • [15] Enteric-coated mycophenolate sodium (EC-MPS) vs mycophenolate mofetil (MMF) in de novo heart transplant patients: 6-month efficacy and safety results.
    Kobashigawa, JA
    Davis, SF
    Renlund, DG
    Eisen, H
    Miller, L
    Lehmkuhl, H
    Gambino, A
    Brambilla, R
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 281 - 281
  • [16] Pharmacokinetics of enteric-coated mycophenolate sodium in de novo renal transplant patients in combination with tacrolimus: Results of a 6-month stud
    Kaplan, Bruce
    Chan, Laurence
    Messa, Piergiorgio
    Mulgaonkar, Shamkant
    Koelle, Ernst-Ulrich
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 582 - 582
  • [17] Renal function with enteric-coated mycophenolate sodium in combination with reduced and standard tacrolimus levels: Results of a 6-month comparative study in de novo renal transplant recipients
    Hart, Marquis
    Chan, Laurence
    Andres, Amado
    Bloom, Roy
    Bunnapradist, Suphamai
    Kaplan, Bruce
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 583 - 583
  • [18] Efficacy and safety of enteric-coated mycophenolate sodium in Chinese living-donor kidney transplant recipients: A multicenter prospective cohort study
    Mo, Chunbai
    Wang, Changxi
    Men, Tongyi
    Xie, Jinliang
    Zhang, Aiming
    TRANSPLANTATION, 2016, 100 (07) : S719 - S719
  • [19] Twelve months results of enteric-coated mycophenolate sodium (EC-MPS) in de novo heart transplant patients showed excellent efficacy and safety
    Kobashigawa, J. A.
    Renlund, D. G.
    Gerosa, G.
    Caforio, A.
    Ross, H.
    Lehmkuhl, H. B.
    Eisen, H.
    Segovia, J.
    Brambilla, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (02): : S166 - S166
  • [20] Results of a 6-month, multicenter, open-label, prospective study concerning efficacy and safety of mycophenolate sodium in de novo kidney transplant recipients
    Wyzgal, J.
    Niemczyk, M.
    Ziolkowski, J.
    Durlik, M.
    Wiecek, A.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (09) : 2730 - 2732